Ionis announces zilganersen New Drug Application for Alexander disease (AxD) accepted by FDA for Priority Review

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. IBM
2. PRIM
3. META
4. NAVN
5. CNC
6. KFY
7. ABBV
8. MU
9. DPZ
10. PLTR

Go back to Ionis announces zilganersen New Drug Application for Alexander disease (AxD) accepted by FDA for Priority Review
(NASDAQ: IONS) Delayed: 75.89 --0 (-0%)
Previous Close $75.89    52 Week High $62.68 
Open $75.89    52 Week Low $19.59 
Day High $75.89    P/E N/A 
Day Low $75.89    EPS $0.00 
Volume 195